Through
11/26
While advances in technology have made multigene testing, or “panel testing,” for genetic mutations that increase the risk of breast or other cancers an option, authors of a review published today in the New England Journal of Medicine say larger studies are needed in orde
The rapidly emerging field of precision medicine is a “disruptive innovation” that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week’s issue of the New England Journal of Medicine.
A cancer patient’s expectations about the benefits of complementary and alternative (CAM) and their perceived access to CAM therapies are likely to guide whether or not they will use those options, according to a new study published ahead of print in the journal CANCER from researchers at Abramson Cancer Center of the University of Pennsylvania.
It’s a long road from the University of Pennsylvania to Amsterdam, but cancer research knows no bounds.
Kevin Volpp, MD, PhD, was presented with the 2015 Association for Clinical and Translational Science (ACTS) Distinguished Investigator Award for Career Achievement and Contribution to Clinical and Translational Science for translation from clinical use into public benefit and policy at the organization’s sixth annual meeting last month in Washington, D.C.
An important link between the human body clock and the immune system has relevance for better understanding inflammatory and infectious diseases, discovered collaborators at the Perelman School of Medicine at the University of Pennsylvania and Trinity College, Dublin.
Researchers from the Perelman School of Medicine at the University of Pennsylvania received a $400,000 grant from the Caring for Carcinoid Foundation (CFCF), a non-profit that funds research for carcinoid, pancreatic, and related neuroendocrine cancers (NETS), to investigate the use of an experimental gene therapy that engineers immune cells to attack cancers.
After a major earthquake hit Nepal on April 25, University of Pennsylvania graduate student Sandeep Shah felt helpless. But, he also knew that his interdisciplinary background in social work, finance and philanthropy could help those who needed it the most.
In the first-of-its-kind study since the passage of the HIV Organ Policy Equity Act (the HOPE Act), which lifted the ban on organ donations from one HIV-positive person to another, Penn Medicine researchers report on the quality of these organs and how their use might impact the country’s organ shortage.
Four different financial incentive programs, each worth roughly $800 over six months, all help more smokers kick the habit than providing free access to behavioral counseling and nicotine replacement therapy.
The National Institutes of Health have awarded $11 million to Aimin Chen of the Perelman School of Medicine to study the link between chemical exposures and dementia.
FULL STORY →
A COVID patient who survived his coma recently reunited with the Penn Medicine care team that helped save his life, including Jennifer Olenik of the Perelman School of Medicine.
FULL STORY →
Research published by Marianne Nabbout while a resident at the Perelman School of Medicine finds that vaping has an immediate effect on blood vessels even if an e-cigarette doesn’t contain nicotine.
FULL STORY →
A former COVID patient who spent six months in a coma returned to thank the Penn Medicine team that contributed to his survival, including Megan Carr-Lettieri.
FULL STORY →
According to Penn Medicine, about 1 in 4 Americans experiences difficulty with sleep each year.
FULL STORY →